Xiaonan Chen

504 total citations
30 papers, 402 citations indexed

About

Xiaonan Chen is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Xiaonan Chen has authored 30 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Complementary and alternative medicine. Recurrent topics in Xiaonan Chen's work include Ginseng Biological Effects and Applications (6 papers), Pharmacological Effects of Natural Compounds (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Xiaonan Chen is often cited by papers focused on Ginseng Biological Effects and Applications (6 papers), Pharmacological Effects of Natural Compounds (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Xiaonan Chen collaborates with scholars based in China, United States and United Kingdom. Xiaonan Chen's co-authors include Pengfei Tu, Yunfang Zhao, Jun Li, Zhixiang Zhu, Jing Sun, Yuelin Song, Shouying Du, Pengyue Li, Ailin Yang and Yang Lu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biochemical Pharmacology.

In The Last Decade

Xiaonan Chen

27 papers receiving 395 citations

Peers

Xiaonan Chen
Kian Lam Lim Malaysia
Khong Trong Quan South Korea
Ha-Rim Kim South Korea
Shi‐Yong Ryu South Korea
Elbert L. Myles United States
Quan Cheng Chen South Korea
Jun Yin China
Kian Lam Lim Malaysia
Xiaonan Chen
Citations per year, relative to Xiaonan Chen Xiaonan Chen (= 1×) peers Kian Lam Lim

Countries citing papers authored by Xiaonan Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaonan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonan Chen more than expected).

Fields of papers citing papers by Xiaonan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaonan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonan Chen. The network helps show where Xiaonan Chen may publish in the future.

Co-authorship network of co-authors of Xiaonan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaonan Chen. A scholar is included among the top collaborators of Xiaonan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaonan Chen. Xiaonan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Weiwei, Yingran Liang, Xiaonan Chen, et al.. (2025). Identification of Lauric Acid as a Potent Sodium Channel NaV1.5 Blocker from Compound Chinese Medicine Wenxin Keli. Drug Design Development and Therapy. Volume 19. 141–157.
3.
Ma, Ping, Chongsheng Peng, Ying Peng, et al.. (2023). A mechanism of Sijunzi decoction on improving intestinal injury with spleen deficiency syndrome and the rationality of its compatibility. Journal of Ethnopharmacology. 306. 116088–116088. 13 indexed citations
4.
Tian, Yingying, Longyan Wang, Xiaonan Chen, et al.. (2023). DHMMF, a natural flavonoid from Resina Draconis, inhibits hepatocellular carcinoma progression via inducing apoptosis and G2/M phase arrest mediated by DNA damage-driven upregulation of p21. Biochemical Pharmacology. 211. 115518–115518. 12 indexed citations
7.
Cheng, Shaowen, Xiaonan Chen, Hong Huang, et al.. (2022). Rapid conversion of hotels into makeshift hospitals to combat COVID-19 outbreak by Omicron variants of SARS-CoV-2 in Sanya, Hainan. SHILAP Revista de lepidopterología. 2(1). 14–14. 1 indexed citations
8.
Tian, Yingying, Ailin Yang, Xiaonan Chen, et al.. (2021). [Research progress on anti-tumor effect of Chinese dragon's blood].. PubMed. 46(8). 2037–2044. 3 indexed citations
9.
Chen, Xiaonan, Yanan Zhao, Ailin Yang, et al.. (2020). Chinese Dragon’s Blood EtOAc Extract Inhibits Liver Cancer Growth Through Downregulation of Smad3. Frontiers in Pharmacology. 11. 669–669. 15 indexed citations
10.
Sun, Jing, Jiani Liu, Bei Fan, et al.. (2019). Phenolic constituents, pharmacological activities, quality control, and metabolism of Dracaena species: A review. Journal of Ethnopharmacology. 244. 112138–112138. 72 indexed citations
11.
Sun, Jing, Xiaonan Chen, Jiani Liu, et al.. (2019). [Identification of active components in Longxue Tongluo Capsules against ischemic brain injury based on component-activity relationship].. PubMed. 44(1). 150–157. 2 indexed citations
12.
Wang, Li‐Fang, Xiaonan Chen, Jun Li, Pengfei Tu, & Jinling Wang. (2019). [Preparation, characterization and dissolution characteristics of dragon's blood extract nanosuspensions].. PubMed. 44(11). 2236–2243. 1 indexed citations
13.
Yang, Ailin, Haitao Fan, Yanan Zhao, et al.. (2019). An immune-stimulating proteoglycan from the medicinal mushroom Huaier up-regulates NF-κB and MAPK signaling via Toll-like receptor 4. Journal of Biological Chemistry. 294(8). 2628–5268. 45 indexed citations
14.
Zhao, Yanan, Ailin Yang, Xiaoqin Su, et al.. (2019). [Anti-tumor activity of HIS-4,a biflavonoid from Resina draconis,on human hepatoma HepG2 and SK-HEP-1 cells].. PubMed. 44(7). 1442–1449. 1 indexed citations
15.
Zhang, Wantong, Yang Lu, Rui Gao, et al.. (2018). Network pharmacology-based identification of protective mechanism of Panax Notoginseng Saponins on aspirin induced gastrointestinal injury. Biomedicine & Pharmacotherapy. 105. 159–166. 57 indexed citations
16.
Wang, Taiyi, Xiaonan Chen, Jiahui Yu, et al.. (2018). High-Throughput Electrophysiology Screen Revealed Cardiotoxicity of Strychnine by Selectively Targeting hERG Channel. The American Journal of Chinese Medicine. 46(8). 1825–1840. 4 indexed citations
17.
Huo, Hui-Xia, Yufan Gu, Zhixiang Zhu, et al.. (2018). LC-MS-guided isolation of anti-inflammatory 2-(2-phenylethyl)chromone dimers from Chinese agarwood (Aquilaria sinensis). Phytochemistry. 158. 46–55. 33 indexed citations
18.
Tian, Zhihao, Huanhuan Pang, Qiang Zhang, et al.. (2018). Effect of aspirin on the pharmacokinetics and absorption of panax notoginseng saponins. Journal of Chromatography B. 1074-1075. 25–33. 22 indexed citations
19.
Wang, Taiyi, Peng Zhang, Xiaonan Chen, et al.. (2017). An integrated anti-arrhythmic target network of a Chinese medicine compound, Wenxin Keli, revealed by combined machine learning and molecular pathway analysis. Molecular BioSystems. 13(5). 1018–1030. 16 indexed citations
20.
Chen, Xiaonan, Danqi Li, Shouying Du, et al.. (2017). Pharmacokinetics of Panax notoginseng Saponins in Adhesive and Normal Preparation of Fufang Danshen. European Journal of Drug Metabolism and Pharmacokinetics. 43(2). 215–225. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026